Acadia Healthcare (NASDAQ:ACHC) Rating Lowered to Neutral at Bank of America

Acadia Healthcare (NASDAQ:ACHC) was downgraded by Bank of America from a “buy” rating to a “neutral” rating in a research note issued to investors on Wednesday, MarketBeat.com reports. They presently have a $25.00 price target on the stock. Bank of America‘s price target would suggest a potential upside of 7.30% from the stock’s previous close.

A number of other brokerages also recently commented on ACHC. Wall Street Zen raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Sunday, August 3rd. Barclays lowered their target price on Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating for the company in a report on Thursday, August 7th. KeyCorp lowered their target price on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. UBS Group lowered their target price on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Finally, Stephens upgraded Acadia Healthcare to a “hold” rating in a report on Monday, June 2nd. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Acadia Healthcare has a consensus rating of “Moderate Buy” and an average target price of $39.00.

Acadia Healthcare Stock Up 3.4%

Shares of NASDAQ ACHC opened at $23.30 on Wednesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market capitalization of $2.15 billion, a price-to-earnings ratio of 15.43, a PEG ratio of 4.43 and a beta of 0.89. The stock has a 50 day moving average price of $22.20 and a 200 day moving average price of $24.58. Acadia Healthcare has a 52-week low of $17.13 and a 52-week high of $79.82.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. The firm had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.Acadia Healthcare’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Sell-side analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd raised its stake in Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock worth $38,000 after acquiring an additional 1,234 shares during the last quarter. UMB Bank n.a. raised its stake in Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock worth $38,000 after acquiring an additional 755 shares during the last quarter. Allworth Financial LP raised its stake in Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after acquiring an additional 1,177 shares during the last quarter. State of Wyoming purchased a new position in Acadia Healthcare in the 4th quarter worth $56,000. Finally, EverSource Wealth Advisors LLC raised its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.